Topical Treatment of Actinic Keratoses with Piroxicam 1% GelA Preliminary Open-Label Study Utilizing a New Clinical Score

被引：0
|
作者：
Elena Campione
Laura Diluvio
Evelin Jasmine Paternò
Sergio Chimenti
机构：
[1] University of Rome “Tor Vergata”,Department of Dermatology
来源：
American Journal of Clinical Dermatology | 2010年 / 11卷
关键词：
Hyaluronic Acid; Piroxicam; Imiquimod; Actinic Keratose; Etretinate;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Background: The cyclo-oxygenase enzymes 1 and 2 (COX-1 and COX-2) are both involved in skin tumorigenesis, causing inhibition of apoptosis, angiogenesis, invasiveness, recruitment of growth factors, immunosuppression, and production of carcinogens. Piroxicam is a nonselective nonsteroidal anti-inflammatory drug that blocks the activity of COX-1 and COX-2.
引用
收藏
页码：45 / 50
页数：5
相关论文
共 50 条
  • [31] A Single-Arm, Open-Label, Phase IV Study to Evaluate the Efficacy of a Topical Formulation for Hyperkeratotic Actinic Keratosis Lesions
    De Padova, Maria Pia
    Marzani, Barbara
    Pinto, Daniela
    Rinaldi, Fabio
    DERMATOLOGY AND THERAPY, 2018, 8 (03) : 455 - 462
  • [32] A Single-Arm, Open-Label, Phase IV Study to Evaluate the Efficacy of a Topical Formulation for Hyperkeratotic Actinic Keratosis Lesions
    Maria Pia De Padova
    Barbara Marzani
    Daniela Pinto
    Fabio Rinaldi
    Dermatology and Therapy, 2018, 8 : 455 - 462
  • [33] Topical bimatoprost in the treatment of eyelash loss in alopecia totalis and universalis: A prospective, open-label study
    Ricar, Jan
    Cetkovska, Petra
    Hordinsky, Maria
    Ricarova, Renata
    DERMATOLOGIC THERAPY, 2022, 35 (06)
  • [34] An open-label study of topical tacrolimus ointment 0.1% under occlusion for the treatment of pyoderma gangrenosum
    Kontos, A
    Kerr, H
    Fivenson, D
    Remishofsky, C
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2005, 52 (03) : P115 - P115
  • [35] Heated Lidocaine/tetracaine Topical Patch For Treatment Of Painful Patellar Tendinopathy: An Open-label Study
    Goitz, Henry
    Marriott, Thomas
    MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 2012, 44 : 117 - 117
  • [36] An open-label study of topical tacrolimus ointment 0.1% under occlusion for the treatment of pyoderma gangrenosum
    Kontos, Andrew P.
    Kerr, Holly A.
    Fivenson, David P.
    Remishofsky, Christopher
    Jacobsen, Gordon
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2006, 45 (11) : 1383 - 1385
  • [37] Deep transcranial magnetic stimulation for the treatment of auditory hallucinations: a preliminary open-label study
    Rosenberg, Oded
    Roth, Yiftach
    Kotler, Moshe
    Zangen, Abraham
    Dannon, Pinhas
    ANNALS OF GENERAL PSYCHIATRY, 2011, 10
  • [38] Agomelatine in the Treatment of Fibromyalgia A 12-Week, Open-Label, Uncontrolled Preliminary Study
    Bruno, Antonio
    Mico, Umberto
    Lorusso, Simona
    Cogliandro, Nadia
    Pandolfo, Gianluca
    Caminiti, Maurizio
    Zoccali, Rocco A.
    Muscatello, Maria R. A.
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2013, 33 (04) : 507 - 511
  • [39] Deep transcranial magnetic stimulation for the treatment of auditory hallucinations: a preliminary open-label study
    Oded Rosenberg
    Yiftach Roth
    Moshe Kotler
    Abraham Zangen
    Pinhas Dannon
    Annals of General Psychiatry, 10
  • [40] Effect of sequential applications of topical tacrolimus and topical corticosteroids in the treatment of pediatric atopic dermatitis: An open-label pilot study
    Kubota, Yasuo
    Yoneda, Kozo
    Nakai, Kozo
    Katsuura, MD'Junko
    Moriue, Tetsuya
    Matsuoka, Yoshie
    Miyamoto, Izumi
    Ohya, Yuldhiro
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2009, 60 (02) : 212 - 217
12345